AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ
Endocrinology · 2024
DOI: 10.1210/endocr/bqae018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Yujun Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, 261041, P.R. China. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Shandong Province College Science and Technology Plan Project.
Abstract (Originalsprache)
Ovarian endometriosis (EMs) is a benign, estrogen-dependent gynecological disorder. Estrogen receptor beta (ERβ), a nuclear receptor for estradiol, plays an important role in the development of ovarian EMs. Here, we investigated the biological significance of aurora kinase A (AURKA) in ovarian EMs and the mechanism by which it regulates ERβ. We used immunohistochemical assays to verify that AURKA and ERβ were highly expressed in ectopic endometrial tissues. Cell proliferation and colony formation assays were used to demonstrate that AURKA promoted the proliferation of EMs cells. Wound-healing assay, Transwell migration assay, and Matrigel invasion assay further showed that AURKA enhanced the ability of EMs cells to migrate and invade. In addition, AURKA was shown to stimulate glycolysis in EMs cells by measuring the concentration of glucose and lactate in the cell supernatants. Moreover, the AURKA inhibitor alisertib was found to inhibit the progression of ovarian EMs and glycolysis in a mouse model of EMs by measuring ectopic tissues as well as by testing the peritoneal fluid of mice. Furthermore, coimmunoprecipitation assay showed that AURKA interacted with ERβ. The rescue experiments confirmed that AURKA regulated the development and glycolysis of ovarian EMs in an ERβ-dependent manner. AURKA contributed to the development of ovarian EMs by upregulating of ERβ. AURKA may represent a new target for the treatment of ovarian EMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, 261041, P.R. China.
- Department of Emergency, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, 261041, P.R. China.
- School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, 261053, P.R. China.
- Department of Obstetrics and Gynecology, Zhucheng People's Hospital, Shandong Second Medical University, Weifang, Shandong Province, 262299, P.R. China.
ORCID-Profile: Aifang Jiang, Tingting Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Shandong Province College Science and Technology Plan Project
- Clinical Research Center of Affiliated Hospital of Weifang Medical University
Zitieren
APA
Sun, Y., Zhang, S., Zhang, X., Li, G., Sun, F., Wang, M., Ren, C., Jiang, A., & Yang, T. (2024). AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ. Endocrinology. https://doi.org/10.1210/endocr/bqae018
Vancouver
Sun Y, Zhang S, Zhang X, Li G, Sun F, Wang M, et al. AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ. Endocrinology. 2024. doi:10.1210/endocr/bqae018
BibTeX
@article{Sun2024,
author = {Sun, Yujun and Zhang, Shucai and Zhang, Xiaohui and Li, Guotao and Sun, Fangyuan and Wang, Mengxue and Ren, Chune and Jiang, Aifang and Yang, Tingting},
title = {AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ},
journal = {Endocrinology},
year = {2024},
doi = {10.1210/endocr/bqae018}
}
EUVIMED